You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
16 March 2021
Alfasigma has recruited a new head for its Italian business, Bausch Health is making changes at the top, Sanofi is adding two directors to its board, and the US Council for Responsible Nutrition (CRN) has announced three promotions.
10 February 2021
Sanofi Consumer Healthcare plans to divest around 60% of its brands over the next two years, reducing its portfolio from more than 250 brands to roughly 100.
10 February 2021
Sanofi Consumer Healthcare is “on track” with the key studies needed to switch Cialis (tadalafil) and Tamiflu (oseltamivir) from prescription-to-OTC status in the US, according to chief science officer Josephine Fubara.
10 February 2021
Sanofi's Consumer Healthcare business reported worldwide sales down by 3.0% in the fourth quarter of 2020, as social distancing and other measures to control the COVID-19 pandemic meant fewer people suffered from coughs, colds and flu.
12 January 2021
Procter & Gamble (P&G) has abandoned its proposed acquisition of Billie, AFT Pharmaceuticals’ Maxigesic pain reliever has been launched in Canada as Combogesic, and Sanofi has revealed the name and chief of its proposed active pharmaceutical ingredients (API) company.
31 December 2020
Sanofi’s Allevia – containing the antihistamine fexofenadine hydrochloride – has been switched from prescription-only to general sales list (GSL) status in the UK.
2 November 2020
Sanofi Consumer Healthcare has an opportunity to reach its consumers through “cutting-edge digital platforms”, according to new worldwide head Julie Van Ongevalle, who adds that the business needs to focus on building “true hero products” and leveraging “strong consumer innovation”.
2 November 2020
Sanofi's Consumer Healthcare business reported worldwide sales down by 1.1% in the third quarter of 2020, as the voluntary recall of Zantac in the US and Canada in October 2019 continued to have an impact.
23 October 2020
Sanofi Consumer Healthcare is set to launch Enzymatica’s common cold spray, ColdZyme, under its established brands in France and Italy.
25 August 2020
Sanofi's Consumer Healthcare business reported worldwide sales down by 8.0% at constant exchange rates in the second quarter of 2020. Paul Hudson, Sanofi's chief executive officer, said the Consumer Healthcare business would take a more assertive stance in the online sector under its new worldwide h...